🇺🇸 quetiapine fumarate tablets in United States

268 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 268

Most-reported reactions

1. Drug Ineffective — 57 reports (21.27%)
2. Toxicity To Various Agents — 53 reports (19.78%)
3. Drug Interaction — 27 reports (10.07%)
4. Electrocardiogram Qt Prolonged — 21 reports (7.84%)
5. Intentional Overdose — 21 reports (7.84%)
6. Somnolence — 21 reports (7.84%)
7. Product Quality Issue — 20 reports (7.46%)
8. Weight Increased — 18 reports (6.72%)
9. Hypotension — 15 reports (5.6%)
10. Sedation — 15 reports (5.6%)

Source database →

Frequently asked questions

Is quetiapine fumarate tablets approved in United States?

quetiapine fumarate tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for quetiapine fumarate tablets in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.